K
Kenji Yamazaki
Researcher at Asahikawa Medical University
Publications - 143
Citations - 2563
Kenji Yamazaki is an academic researcher from Asahikawa Medical University. The author has contributed to research in topics: Ventricular assist device & Heart failure. The author has an hindex of 25, co-authored 136 publications receiving 2084 citations.
Papers
More filters
Journal ArticleDOI
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―
Hiroyuki Tsutsui,Mitsuaki Isobe,Hiroshi Ito,Ken Okumura,Minoru Ono,Masafumi Kitakaze,Koichiro Kinugawa,Yasuki Kihara,Yoichi Goto,Issei Komuro,Yoshikatsu Saiki,Yoshihiko Saito,Yasushi Sakata,Naoki Sato,Yoshiki Sawa,Akira Shiose,Wataru Shimizu,Hiroaki Shimokawa,Yoshihiko Seino,Koichi Node,Taiki Higo,Atsushi Hirayama,Miyuki Makaya,Tohru Masuyama,Toyoaki Murohara,Shin-ichi Momomura,Masafumi Yano,Kenji Yamazaki,Kazuhiro Yamamoto,Tsutomu Yoshikawa,Michihiro Yoshimura,Masatoshi Akiyama,Toshihisa Anzai,Shiro Ishihara,Takayuki Inomata,Teruhiko Imamura,Yu-ki Iwasaki,Tomohito Ohtani,Katsuya Onishi,Takatoshi Kasai,Mahoto Kato,Makoto Kawai,Yoshiharu Kinugasa,Shintaro Kinugawa,Toru Kuratani,Shigeki Kobayashi,Yasuhiko Sakata,Atsushi Tanaka,Koichi Toda,Takashi Noda,Kotaro Nochioka,Masaru Hatano,Takayuki Hidaka,Takeo Fujino,Shigeru Makita,Osamu Yamaguchi,Uichi Ikeda,Takeshi Kimura,Shun Kohsaka,Masami Kosuge,Masakazu Yamagishi,Akira Yamashina +61 more
TL;DR: This English language document is a revised digest version of Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure (JCS 2017/JHFS 2017) reported at the Japanese Circulation Society Joint Working Groups performed in 2017.
Journal ArticleDOI
Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation.
Trevor A. Snyder,Hiroyuki Tsukui,Shinichiro Kihara,Takehide Akimoto,Kenneth N. Litwak,Marina V. Kameneva,Kenji Yamazaki,William R. Wagner +7 more
TL;DR: Two new methods to quantify bovine activated platelets using antibodies to CD62P and CD63 were characterized and applied and were able to differentiate between two biocompatible coatings and assess effects of anticoagulation regimen in VAD preclinical testing.
Journal ArticleDOI
Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease.
Yoshiki Sawa,Yasushi Yoshikawa,Koichi Toda,Satsuki Fukushima,Kenji Yamazaki,Minoru Ono,Yasushi Sakata,Nobuhisa Hagiwara,Koichiro Kinugawa,Shigeru Miyagawa +9 more
TL;DR: This study demonstrated the feasibility and safety of the transplantation of TCD-51073 in the patients with severe chronic HF due to ischemic heart disease, suggesting that TCD -51073 might maintain or improve cardiac function, symptoms, and physical function.
Journal Article
Guidelines for Treatment of Acute Heart Failure (JCS 2011) : Digest Version
Tohru Izumi,Atsushi Hirayama,Mitsuaki Isobe,Hiroshi Ito,Masafumi Kitakaze,Momomura Shin-ichi,Yoshiki Sawa,Yoshihiko Seino,Hiroyuki Tsutsui,Kenji Yamazaki,Tsutomu Yoshikawa,Hitoshi Adachi,Toshihisa Anzai,Naoyoshi Aoyama,Yoichi Goto,Kazuhiko Hashimura,Takayuki Inomata,Mahoto Kato,Shintaro Kinugawa,Kazufumi Nakamura,Kazuhiko Nishigaki,Shinichi Niwano,Katsuya Onishi,Taketoshi Ozawa,Yasushi Sakata,Naoki Sato,Yukihito Sato,Sugiyama Kato Tomoko,Tsuchihashi Makaya Miyuki,Kazuhiro Yamamoto,Yoshio Yasumura,Hiroyuki Yokoyama,Masatsugu Hori,Tsutomu Imaizumi,Takeshi Nakatani,Keijiro Saku,Michihiro Yoshimura +36 more
TL;DR: This English language document is a revised digest version of Guidelines for Treatment of Acute Heart Failure reported at the Japanese Circulation Society Joint Working Groups performed in 2010.
Journal ArticleDOI
EVAHEART: an implantable centrifugal blood pump for long-term circulatory support.
Kenji Yamazaki,Shinichiro Kihara,Takehide Akimoto,Osamu Tagusari,Akihiko Kawai,Mitsuo Umezu,Jun Tomioka,Robert L. Kormos,Bartley P. Griffith,Hiromi Kurosawa +9 more
TL;DR: The EVAHEART centrifugal blood pump demonstrated excellent performance in long-term in-vivo experiments, and no major organ thromboembolisms occurred except for a few small renal infarcts.